Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Y.J. Lavallée
Observed names:
Y J Lavallee,
Y J Lavallée
Observed institutions:
Université de Sherbrooke,
Centre Hospitalier Universitaire de Sherbrooke
OpenAlex ID:
A5111573130
Elevated plasma levels of neuropeptide Y in patients with panic disorder
1996
·
J P Boulenger
, I Jerabek
, et al.
·
American Journal of Psychiatry
·
47
Mixed anxiety and depression: diagnostic issues.
1993
·
J P Boulenger
, Y J Lavallée
·
PubMed
·
33
The treatment of negative symptoms: a clinical and methodological study
1999
·
Y D Lapierre
, C Angus
, et al.
·
International Clinical Psychopharmacology
·
13
Plasma neuropeptide Y reactivity to cholecystokinin challenge in panic disorders and normal controls
1997
·
J.P. Boulenger
, I. Jerabek
, et al.
·
Biological Psychiatry
·
3
Plasma and platelet catecholamine concentrations as predictors of the cardiovascular, psychological and panic-like-symptoms induced by CCK-4 in healthy subjects
1997
·
I. Jerabek
, J.P. Boulenger
, et al.
·
Biological Psychiatry
·
1
P-5-33 Peripheral monoamines and CCK4-induced panic attacks in healthy subjects
1995
·
I. Jerabek
, J.P. Boulenger
, et al.
·
European Neuropsychopharmacology
·
1
Are benzodiazepines useful in the treatment of generalized anxiety disorders?
1993
·
Y.J. Lavallée
, F.B. Jolicoeur
, et al.
·
European Neuropsychopharmacology
·
1
Positive correlations between peripheral plasmatic neuropeptide Y levels and panic disorder duration in man
1999
·
Aziz Hermès
, Jean‐Philippe Boulenger
, et al.
·
The European Journal of Psychiatry
Human plasma NPY-like immunoreactivity in patients with depressive and panic disorder
1997
·
A. Hermès
, J.P. Boulenger
, et al.
·
Biological Psychiatry
P-7-5 Would CCK-4 challenges be useful to predict anti-anxiety effects of non anti-panic drugs?
1995
·
J.P. Boulenger
, I. Jerabek
, et al.
·
European Neuropsychopharmacology
Show more works
View as search
Works count:
10
Citation count:
99
H-index:
3
I10-index:
3
Year
Topic
Type
